Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

Charles River Laboratories International, Inc. (CRL) reported third-quarter 2024 adjusted earnings per share (EPS) of $2.59, which declined 4.8% year over year. The figure, however, surpassed the Zacks Consensus Estimate by 6.6%.On a GAAP basis, earnings declined 21.3% year over year to $1.33 per share.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.RevenuesRevenues totaled $1.01 billion, beating the Zacks Consensus Estimate by 3.4%. However, the top line declined 1.6% from the year ...